These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 10677399

  • 1. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO, MacFadyen RJ, Struthers AD.
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [Abstract] [Full Text] [Related]

  • 2. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF, MacFadyen RJ, Struthers AD.
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 5. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G, Lauri G, Assanelli E, Grazi M, Guazzi M, Berna G, Salvioni A, Agostoni P.
    Cardiologia; 1997 Dec 26; 42(12):1277-83. PubMed ID: 9534323
    [Abstract] [Full Text] [Related]

  • 6. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH.
    Am J Hypertens; 1999 May 26; 12(5):451-9. PubMed ID: 10342782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
    Ueda T, Kawakami R, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.
    Circ J; 2015 May 26; 79(6):1307-14. PubMed ID: 25753468
    [Abstract] [Full Text] [Related]

  • 12. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L, Rutkowski P, Renke M, Larczyński W, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B.
    Am J Kidney Dis; 2008 Sep 26; 52(3):486-93. PubMed ID: 18423812
    [Abstract] [Full Text] [Related]

  • 13. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ, Jansen RW, Sweep FC, Hoefnagels WH.
    Eur J Heart Fail; 2003 Jan 26; 5(1):47-53. PubMed ID: 12559215
    [Abstract] [Full Text] [Related]

  • 14. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ.
    Am Heart J; 2001 May 26; 141(5):800-7. PubMed ID: 11320369
    [Abstract] [Full Text] [Related]

  • 15. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK.
    Am J Hypertens; 1999 Apr 26; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [Abstract] [Full Text] [Related]

  • 16. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC.
    Circulation; 2004 Apr 06; 109(13):1680-5. PubMed ID: 15023890
    [Abstract] [Full Text] [Related]

  • 17. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G, Bhat G.
    Cardiol Clin; 2014 Feb 06; 32(1):21-32, vii. PubMed ID: 24286576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S, Greene P, Ryan T, Cerimele B, Schwertschlag U, Weinberger M, Voelker J.
    Br J Clin Pharmacol; 1995 Jan 06; 39(1):51-7. PubMed ID: 7756099
    [Abstract] [Full Text] [Related]

  • 20. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
    Good JM, Brady AJ, Noormohamed FH, Oakley CM, Cleland JG.
    Circulation; 1994 Jul 06; 90(1):220-4. PubMed ID: 8026000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.